OraSure Will Conduct New Clinical Trial For Pending PMA
This article was originally published in The Gray Sheet
Executive Summary
OraSure Technologies must conduct a new clinical trial to support its OraQuick Hepatitis C (HCV) test PMA application, after an about-face by FDA reviewers, the firm said last week